￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Mechanisms of resistance are critical to guide treatment selection after osimertinib treatment in EGFR+ non-small cell lung cancer

2026-02-01 22:25:32

Check Details
Eltrombopag/eltrombopag efficacy and side effects

2026-02-01 22:25:32

Check Details
6 taboos about dolopastine/romigrastim

2026-02-01 22:25:32

Check Details
Axitinib/axitinib targeted drug insert core content

2026-02-01 22:25:32

Check Details
How to adjust the dose of trametinib for optimal results

2026-02-01 22:25:32

Check Details
Can long-term use of imatinib maintain survival?

2026-02-01 22:25:32

Check Details
Ruxolitinib/ruxolitinib cream shows long-term AD control in children 2 to 11 years old

2026-02-01 22:25:32

Check Details
How long does a complete course of Jisandai/Bingtonsha treatment take?

2026-02-01 22:25:32

Check Details
What information is included in the Chinese detailed instructions for tazestat

2026-02-01 22:25:32

Check Details
Generational classification and efficacy analysis of ceritinib targeted drugs

2026-02-01 22:25:32

Check Details
Clinical research progress and data on besetifan in the treatment of renal cancer

2026-02-01 22:25:32

Check Details
What is the reimbursement price of dabrafenib in medical insurance?

2026-02-01 22:25:32

Check Details
Category
相关知识